Contact us to get started

Hope begins here.

If you're an HR or benefits professional seeking cancer resources for your employees, or a consultant looking to provide best-in-class cancer support for your clients, share a few details below. We’ll reach out to help your company get started.

If you’re an employee looking for your AccessHope benefit, visit our Member Area.

Unmatched expertise in the fight against cancer

You want the best for your clients and their employees facing cancer and that starts with access to the latest knowledge.

Outcomes are dramatically better at National Cancer Institute (NCI)-Designated Comprehensive Cancer Centers, but only 20% of cases are treated there.1,2 That’s why AccessHope makes it easy to bring the latest expertise to employees by connecting their local oncologists with NCI subspecialists.

HubSpot Video

We proudly partner with NCI centers to remotely deliver expertise to employees and their families nationwide

Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

Read More

Fred Hutchinson Cancer Center

Fred Hutchinson Cancer Center

Read More

Northwestern Medicine

Northwestern Medicine

Read More
Asset 16-final

Cancer isn’t one disease

We now know there are hundreds of cancer types and variants, and optimal treatments can be radically different depending on factors like genetics and stage. AccessHope supports your clients’ employees and their oncologists with expertise related to their specific case, to make a real, measurable, tangible difference.

Asset 15-final

Cancer is costing your clients

Cancer is the top driver of complex care costs. In one year, cancer care can cost employers $103.8 billion, plus $123 billion in absenteeism and lost productivity.3,4 AccessHope can reduce expenses that result from a lack of access to the latest knowledge, including unnecessary testing and inappropriate treatments. It also saves employees unnecessary physical and emotional strain caused by these treatments.
Asset 14-final

Cancer research isn’t reaching everyone

Cancer research is evolving rapidly, but that doesn’t mean it’s reaching everyone equally. Cancer treatments and outcomes can vary by zip code, race, ethnicity, socioeconomic status, sexual orientation and more.5 AccessHope allows your clients to ensures NCI expertise is available to every employee facing a cancer diagnosis, no matter who they are or where they live.

Hear from an AccessHope client

AccessHope is the most impactful program I had the honor of introducing in my last plan sponsor role. I can personally vouch for AccessHope’s program as it gave me the peace of mind of knowing my treatment plan was correct. It’s a scary time and very confusing as one moment you’re totally healthy and the next you have a cancer diagnosis.”

Pat Pitsch

The proof is in the
(peer-reviewed) paper

Our subspecialists provided evidence-based recommendations that had the potential to influence the treatment plan in approximately 93% of cases.6

Download the study

HubSpot Video
+-

What is required from me and my client to implement AccessHope?

For our employee-initiated Expert Advisory Review and Cancer Support Team, AccessHope needs an eligibility file.

For our algorithm-based Accountable Precision Oncology service, AccessHope works with health plan/third-party administrator (TPA) operations to proactively initiate case reviews by clinical experts.

+-

How are you different than other cancer support services?

AccessHope’s employer benefit gives employer self-funded plans and the treating physicians of employees remote access to renowned cancer expertise through foundational partnerships with NCI–Designated Comprehensive Cancer Centers, allowing a 100% focus on cancer.

We bring advanced expert knowledge to advise on clinical aspects of a proposed treatment plan and provide evidence-based recommendations including personalized precision medicine opportunities, as well as appropriate clinical trial information and support services, regardless of an employee’s location.

+-

How is AccessHope different than Centers of Excellence (COE) services?

COE services provide medical care to cancer patients; AccessHope does not. AccessHope’s business model remotely connects (a) employees to cancer support services from expert oncology nurses and support staff via our Cancer Support Team; (b) employees’ community oncologists (via our Expert Advisory Review service) and benefit plans (via our Accountable Precision Oncology service) to the latest expertise from NCI–Designated Comprehensive Cancer Centers, eliminating the need to travel for leading cancer expertise and leaving their care decisions 100% in the hands of their local treating physician. Our program supports all cancer types and stages along the member’s journey, while they stay close to home with their local support system.

+-

How are you different than second opinion or expert medical opinion (EMO) services?

Unlike EMO solutions that provide written case reports to members, AccessHope specialists deliver a detailed report on each unique cancer case to the member’s plan or their community oncologist and follow up with an offer of a peer-to-peer clinical consultation call to discuss the evidenced-based recommendations. AccessHope is focused solely on supporting cancer cases with the latest knowledge from NCI centers to help improve quality of life and health outcomes for more people with cancer.

+-

Are community oncologists willing to collaborate with your subspecialists?

Yes. In more than 90% of cases, AccessHope experts offer recommendations which, if adopted by community oncologists, have the potential to influence meaningful and actionable changes to the recommended treatment plan.

In fact, our innovative model of remote expert case reviews was recently validated by a peer-reviewed study in the medical journal JCO Oncology Practice.

+-

How is AccessHope addressing cancer health disparities?

While science continues to evolve, disparities in healthcare based on race and geography persist. AccessHope’s remote approach to Expert Advisory Review and Accountable Precision Oncology services addresses disparities by providing access to NCI expertise regardless of the employee’s geographic location. Highly specialized hospitals like NCI centers have been shown in a study to have higher survival rates over 5 years versus community hospitals.1

As an organization, AccessHope also administers diversity, equity, and inclusion training for their physician, clinical and research teams on empathy, authentic communication, unconscious bias and other related topics.

Reference

1 Pfister DG, Rubin DM, Elkin EB, et al. Risk adjusting survival outcomes in hospitals that treat patients with cancer without information on cancer stage. JAMA Oncol. 2015;1(9)1303-1310.

+-

How do you provide expertise to employees with cancer? Do they need to travel?

AccessHope services do not require members to travel, but instead provide remote access to leading-edge insights.

+-

How do you handle member privacy?

AccessHope values members’ privacy. All employee information is transmitted, used and stored securely, according to applicable HIPAA guidelines.

Our leaders

Meet the people who are transforming the way we fight cancer

Mark
Stadler

Chief Executive Officer

As CEO, Mark drives the overall strategy and direction of AccessHope. His prior leadership experience includes successes with BridgeHealth, HealthSmart Holdings, Inc., Aon Hewitt, Great-West Healthcare, UnitedHealthcare and more.

David
Lamm

Chief Financial Officer

In David’s role as CFO, he advises on AccessHope’s financial and growth strategies. This role builds on his leadership background in finance, compliance and administration within healthcare and healthcare technology companies such as Ingenious Med, MedData and Kaiser Permanente.

Todd
Sachs, M.D.

Chief Medical Officer

Dr. Todd Sachs leads AccessHope’s clinical team and oversees the remote delivery of our cancer support services. Passionate about addressing healthcare disparities and promoting value-based care, Todd is deeply dedicated to staying in the know on the newest protocols and medications in the always-advancing field of oncology.

 

Board certified by the American Board of Surgery and a fellow of the American College of Surgeons, Todd specializes in endocrine surgery of the thyroid and parathyroid glands. He also belongs to the California Medical Association and Los Angeles Surgical Society.

Jonathan
Smith

Chief Commercial Officer

Jonathan creates a strong customer and consultant experience as CCO.  His history in the healthcare consulting, brokerage, and health plan industries includes significant leadership experience with Arthur J. Gallagher & Co. and Willis Towers Watson.

Abhishek
Kumar

Chief Information Officer

Abhishek is responsible for the management, strategy and operations of IT infrastructure and oversees the IT Strategy and Information Security Program. His experience includes success with Johns Hopkins, City Of Hope and Johnson & Johnson.

Joseph
Alvarnas, M.D.

Chief Clinical Advisor | AccessHope; VP, Government Affairs and Senior Medical Director for Employer Strategy, Clinical Professor, Hematology/HCT | City of Hope

Dr. Alvarnas is AccessHope’s Chief Clinical Advisor with a passion for changing the healthcare system to ensure the delivery of first-class cancer care. He’s also a Clinical Professor of Hematologythe Vice President of Government Affairs, and the Senior Medical Director for Employer Strategy at City of Hope, a world-renowned independent cancer research and treatment center. For the center, he leads advocacy efforts at the federal, state, and local levels, and assists in developing, marketing, and operationalizing the clinical infrastructure and activities related to employer and payer strategies.  

Stacey
Eggleston

Senior Vice President, Client Excellence

Stacey is focused on producing long-term and highly satisfied customer partnerships as Senior VP of Client Excellence. Her experience includes 19 years in different facets of health care, including pharmacy benefit management, well-being, chronic condition management and Medicare. Most recently, she was in a leadership role at Korn Ferry as a global account leader on their health care team.

Sue
Willette

Senior Vice President, Consultant Relations

As AccessHope’s Senior VP, Consultant Relations, Sue leverages more than 35 years of diverse healthcare industry experience to drive business growth for the company’s innovative cancer support services program. 

Melissa
Gilkerson

Vice President, Marketing & Communications

Melissa drives the AccessHope brand and marketing strategy and oversees member engagement. Her 20 years of experience include successive leadership roles with StayWell as well as positions with Willis Towers Watson and RBC Capital Markets.

Cory
Morin

Vice President, Foundational Partners

Cory is the VP of Foundational Partners for AccessHope. He brings 17 years of project/program management and leadership experience in the healthcare industry to his role 

Need help?

We create innovative services that help your employees navigate the sometimes overwhelming world of cancer.

Our goal is to help our members get the best access and optimal results.

Contact our support team

References:

National Cancer Institute. Data table 3: Reportable patients/participation in therapeutic studies. National Institute of Health Web site. https://cancercenters.cancer.gov/DT/DT3. Accessed June 4, 2021.

2 Tangka, F. K., Trogdon, J. G., Nwaise, I., Ekwueme, D. U., Guy, G. P., Jr, & Orenstein, D. (2013). State-level estimates of cancer-related absenteeism costs. Journal of occupational and environmental medicine55(9), 1015–1020. https://doi.org/10.1097/JOM.0b013e3182a2a467

3 American Association for Cancer Research. AACR Cancer Disparities Progress Report 2020. https://cancerprogressreport.aacr.org/wp-content/uploads/sites/2/2020/09/AACR_CDPR_2020.pdf. Published 2020. Accessed October 6, 2020.

4 West HJ, Tan YA, Barzi A, Wong D, Parsley R, Sachs T. Novel program offering remote, asynchronous subspecialist input in thoracic oncology: Early experience and insights gained during the COVID-19 pandemic [published online ahead of print December 3, 2021]. JCO Oncology Practice. doi:10.1200/OP.21.00339